Pyridine → HCID 9798097, 화합물

HRID 1597921노트

반응식

HRID 1597921 반응식
Cl.[Cl:2][C:3]1[CH:11]=[C:10]2[C:6]([CH2:7][CH2:8][NH:9]2)=[CH:5][CH:4]=1.N1C=CC=CC=1.Cl[C:19]1[C:28]2[C:23](=[CH:24][C:25]([O:31][CH3:32])=[C:26]([O:29][CH3:30])[CH:27]=2)[N:22]=[CH:21][N:20]=1>CC(O)C>[Cl:2][C:3]1[CH:11]=[C:10]2[C:6]([CH2:7][CH2:8][N:9]2[C:19]2[C:28]3[C:23](=[CH:24][C:25]([O:31][CH3:32])=[C:26]([O:29][CH3:30])[CH:27]=3)[N:22]=[CH:21][N:20]=2)=[CH:5][CH:4]=1

참가 물질

5

실험 절차

To 6-chloroindoline hydrochloride (1 00 mg, 0.526 mmol) and pyridine (0.957 mmol, 77 μL) in dry i-PrOH (8 mL) was added 4-chloro-6,7-dimethoxyquinazoline (107 mg, 0.478 mmol). The mixture was refluxed for 2 hours under an atmosphere of dry N2(g) and then the solvent was removed in vacuo. The residue was partitioned between CHCl3 and 1M NaOH, and the organic phase was washed with brine, dried over Na2SO4(g) and concentrated in vacuo. The residue (171 mg) was purified by flash chromatography on silica using 80%EtOAc/CH2 Cl2 to yield 4-(6-chloro-2,3-dihydro-indol-1-yl)-6,7-dimethoxy-quinazoline as its free base (148 mg) (M.P. 229°-230° C.; LC-MS: 342 (MH+); anal. RP18-HPLC RT: 4.38 min.).

후처리

  1. temperatureThe mixture was refluxed for 2 hours under an atmosphere of dry N2(g)
  2. customthe solvent was removed in vacuo
  3. customThe residue was partitioned between CHCl3 and 1M NaOH
  4. washthe organic phase was washed with brine
  5. dry with materialdried over Na2SO4(g)
  6. concentrationconcentrated in vacuo
  7. customThe residue (171 mg) was purified by flash chromatography on silica using 80%EtOAc/CH2 Cl2

출처 및 근거

ORD 기록
ord-f3ebcff4d1714bed8453c727bcd8bc72
출처 데이터셋
uspto-grants-1998_04
특허 번호
US05736534

반응 노트

불러오는 중…